As a microorganism of major biotechnological importance, the oleaginous yeast Yarrowia lipolytica is subjected to intensive genetic engineering and functional genomic analysis. Future advancements in this area, however, require a system that will generate a large collection of mutants for high-throughput screening. Here, we report a rapid and efficient method for high-throughput transformation of Y. lipolytica in 96-well plates. We developed plasmids and strains for the large-scale screening of overexpression mutant strains, using Gateway R vectors that were adapted for specific locus integration in Y. lipolytica. As an example, a collection of mutants that overexpressed the alkaline extracellular protease (AEP) was obtained in a single transformation experiment. The platform strain that we developed to receive the overexpression cassette was designed to constitutively express a fluorescent protein as a convenient growth reporter for screening in non-translucid media. An example of growth comparison in skim milk-based medium between AEP overexpression and deletion mutants is provided.
INTRODUCTION
Yarrowia lipolytica is an unconventional hemiascomycete yeast that has long been used as model for the study of protein secretion, hydrophobic substrate utilization, peroxisome biogenesis, dimorphism and mitochondrial complex I (Nicaud 2012) . Recently, Y. lipolytica has also become extremely useful for biolipid conversion and biolipid production studies (Coelho, Amaral and Belo 2010; Beopoulos, Nicaud and Gaillardin 2011; Blazeck et al. 2014) , as well as various other biotechnological applications (Fickers and Nicaud 2013) . In addition, it has emerged as a yeast model for applied and fundamental lipid metabolism studies, since it presents several advantages: a fully sequenced and wellannotated genome, numerous available genetic tools and wellestablished transformation methods.
Initial studies of Y. lipolytica utilized the protoplast transformation method (Gaillardin, Ribet and Heslot 1985) , which was rapidly supplanted by the classical lithium acetate (LiAC) method adapted from Saccharomyces cerevisiae (Davidow et al. 1985; Barth and Gaillardin 1996) . This approach has been optimized and modified over time (Xuan, Fournier and Gaillardin 1988; Chen, Beckerich and Gaillardin 1997) . The electroporation method has also been used with less frequency (Barth and Gaillardin 1996) . Currently, the LiAC transformation method is widely used both for gene deletion and for the integration of expression cassettes into the genome (Le Dall, Nicaud and Gaillardin 1994) . Expression cassettes can be integrated randomly into the chromosome thanks to the Zeta long terminal repeats of Y. lipolytica retrotransposon Ylt1, which usually flank the expression cassette in the autocloning vectors developed by Pignède et al. (2000) . This method has been used for the isolation of tagged insertion mutants Thevenieau et al. 2007) . By taking advantage of the absence of Ylt1 in some strains, a specific locus integration platform has been developed that uses the Zeta sequence in order to target integration at the ura3 locus via single crossing over and homologous recombination (Juretzek et al. 2001; Bordes et al. 2007) .
With the advent of automation tools and functional genomic approaches, technologies are now available for the highthroughput screening of large collections of strains. For example, mutant libraries have been successfully constructed via the random insertion of mutagenesis cassettes (random disruption) with the goal of identifying mutants affected in hydrophobic substrate utilization (Thevenieau et al. 2007) . Likewise, libraries of mutant enzymes were obtained via targeted insertion of the URA3-Zeta platform (enzyme evolution) for the isolation of variants of Y. lipolytica Lip2p (Bordes et al. 2007; Cambon et al. 2010) and Candida antarctica Lipase B (Emond et al. 2010) . However, the single-strain/tube-based transformation method used in these studies does not lend itself to efforts to streamline large-scale systematic gene deletion and systematic gene overexpression; when dealing with large quantities, this method is technically burdensome and inappropriate for the construction of these kinds of high-throughput libraries.
Currently, the most popular method for functional genomic studies uses the Gateway R technology (Rual, Hill and Vidal 2004) , which relies on the development of Gateway vectors, recipient strains and a high-throughput transformation method. Despite increasing interest in Y. lipolytica, this strategy has never been applied in this yeast because of the lack of methodologies for large-scale transformation. There is therefore a need for methods that enable the rapid transformation and analysis of a large set of clones, which also implies the miniaturization of existing procedures. In addition, studies of lipid metabolism, lipases, or proteases in Y. lipolytica rely on the use of certain opaque media (e.g. fatty acid emulsions, skim-milkbased media) in which measurements of optical density cannot be performed automatically and require fastidious sampling and washing. Thus, for the screening of large mutant collections, there is also a need for versatile tools to follow growth in such non-translucid media.
Here, we describe a rapid and efficient method for the highthroughput transformation of Y. lipolytica in 96-well plates. We developed plasmids and strains of Y. lipolytica to enable the construction of an overexpression mutant library using the Gateway technology. Strains contained the RedStar2 fluorescent protein as a reporter for growth analysis in non-translucid media. We provide an example of growth measurements of alkaline extracellular protease (AEP) overexpression mutants in such a medium.
MATERIALS AND METHODS

Strains and media
Escherichia coli TOP10 and DH5α (Invitrogen) were used for transformation and amplification of recombinant plasmids. They were grown at 37
• C on Luria-Bertani medium that was complemented with 50 μg mL −1 kanamycin or 100 μg mL 
Vector and strain construction
Construction of Gateway destination vector
The pBR322 fragment which contained the ori and ampicillin resistance genes was amplified from pDEST14 (Invitrogen) using the primers PBRup and PBRdown (Table 2 ). These two primers each contain the two restriction sites NotI and IceuI. Following digestion by NotI, the dephosphorylated fragment was purified and ligated into the NotI-digested and purified fragment from the JMP62-derivative vector JMP1047, which contains the expression cassette NotI-Zeta-UraEx-pTEF-term-Zeta-NotI. The resulting vector, JMP1521, was verified by restriction and sequencing. The Gateway cassette (attR1-ccdb-chloramphenicol-attR2), which enables recombination using Gateway clonase, was PCR-amplified from pDEST14 (Invitrogen) with the primers bgl2 gate plus and gate Avr2 plus (Table 2 ). This added the BglII and AvrII restriction sites, which thus allowed cloning into JMP1521 between the promoter and the terminator. The purified BglII-AvrII fragment was cloned into JMP1521 vector that had been digested by BamHI and AvrII. The resulting vector, JMP1529, was verified by sequencing.
Construction of the recipient strain for locus-specific integration and constitutive fluorescent reporter gene expression
The pTEF-RedStar2-term cassette was PCR-amplified from the vector JMP1394 (Kabran et al. 2012) with primers containing the AgeI restriction site (F AGE1 tefred, R AGE1 tefred; Table 2 ). The PCR fragment thus contained the RedStar2 sequence surrounded by the pTEF promoter and a terminator. Following AgeI digestion, this fragment was ligated into JMP1226 vector that had been digested by AgeI and dephosphorylated, thus creating vector JMP1490. The orientation of the integration was verified by PCR using two pairs of external and internal primers (61TEFstart/For in Dsred and uraup 1226/leudown 1226; Table  2 ). The JMP1226 vector contains the Zeta platform, LEU2 auxotrophic marker and a unique AgeI restriction site, which together are bookended by upstream and downstream sequences of URA3 for homologous recombination at the URA3 locus in the genome (Lazar et al. 2013) . In this new construction, the Barth and Gaillardin (1996) JMY195 (Po1d) MATa, ura3-302, leu2-270, xpr2-322+pXPR2-SUC2 Barth and Gaillardin (1996) JMY2566 MATa, ura3::pTEF-RedStar2-LEU2ex-Zeta, leu2-270, xpr2-322 This work MATa, This work MATa, This work MATa, This work MATa, This work MATa, This work MATa, ura3::pTEF-RedStar2-LEU2ex, leu2-270, xpr2-322 Lazar et al. (2013) JMY2101 MATa, ura3-302, xpr2-322+pXPR2-SUC2 Barth and Gaillardin (1996) E. coli strain The NotI-digested expression cassette that was extracted from this vector was used to transform the Po1d strain. The upstream and downstream sequences of URA3 allowed integration at the URA3 locus in the genome by double crossing over. The Po1d strain lacks the URA3 gene, which was previously deleted by integration of the S. cerevisiae SUC2 gene (Le Dall, Nicaud and Gaillardin 1994) . Integration of the docking platform (Zeta platform) replaced the ura3::SUC2 (ura3-302) locus with the pTEF-RedStar2-LEU2-Zeta platform (See Fig. 1B) . The resulting strain, named JMY2566, was screened for leucine prototrophy, RedStar2 fluorescence expression, and its inability to grow on sucrose due to the replacement of the ura3::SUC2 locus. Integration at the Zeta locus was verified by PCR on genomic DNA using two primer pairs (Puraextver/RED2 no skl and VerZetasens/Turaextver; Table 2 ). JMY2566 presented the same growth patterns as the wild-type strain W29 on YNB (data not shown).
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Construction of control strains
Vector construction eYFP, RedStar2, SUC2 and XPR2 ORFs were PCR-amplified from JMP911 (unpublished data), JMP1394 (Kabran et al. 2012) , W29 genomic DNA and JMP1462, respectively (Lazar et al. 2013 ), using primers that introduced attB sites on both ends of the PCR product (Attb1-gene name, Attb2-gene name; listed in Table 2 ). Each PCR fragment was then cloned into the pDONR207 vector (Invitrogen) using Gateway BP Clonase according to the manufacturer's instructions and transformed into Mach1T1 E. coli. The resulting entry vectors JMP1594 (eYFP), JMP1592 (XPR2), JMP1593 (SUC2) and JMP1595 (RedStar2) were verified by sequencing. Each ORF was also transferred to the Y. lipolytica-specific destination vector JMP1529 using Gateway LR Clonase according to the manufacturer's instructions, then transformed into Mach1T1 E. coli. This process yielded the expression vectors JMP1598 (SUC2), JMP1599 (eYFP), JMP1600 (RedStar2) and JMP1603 (XPR2), which were verified by PCR and by restriction. The resulting vectors are listed in Table 1 . The resulting expression cassettes contained the attB site between the pTEF promoter and the gene of interest.
Yarrowia lipolytica strain construction
The four expression vectors obtained above were digested by NotI. The purified expression cassettes were transformed into JMY2566 using the LiAC method. For the four strains JMY2811 (RedStar2), JMY2812 (eYFP), JMY2813 (XPR2) and JMY2815 (SUC2), integration at the Zeta docking platform was verified by PCR as described in the following section. To obtain a control strain, we transformed JMY2566 with the NotI cassette from the empty vector JMP1047, which contained the pTEF promoter, the LIP2 terminator and the cloning site BamHI-AvrII without an insert; the resulting strain was designated JMY2810. All constructed strains are listed in Table 1 .
Verification of expression cassette integration at the Zeta platform
PCRs were performed on Y. lipolytica colonies that had been lysed with 10 μL of 0.2 N NaOH and incubated in a thermocycler for 5 min at 99
• C. Integration at the Zeta platform was verified via PCR using the primer pair ATTR2zetaup/Turadown ( Table 2 ). The primer ATTR2zetaup has two possible sites of hybridization. Without integration at the platform, the PCR product yields a band of 2680 bp, while with integration, the PCR product generates a band of 1052 bp (see Fig. 1B and C). Thus, this primer pair allows the simultaneous detection of both specific locus integration and random integration. Theoretically, in the case of locus integration, the forward primer ATTR2zetaup is able to hybridize upstream of the LEU2 gene, which would allow amplification of a fragment larger than 4 kb (see Fig. 1C ), depending on the size of the insert. In practice, using an extension time of 2 min 45 s during PCR, we did not detect this large PCR product.
Transformation methods
Transformation of expression cassettes into Y. lipolytica strains was performed using a miniaturized protocol adapted for the 96-well plate format, described below. The following transformation methods were performed in 96-well PCR plates, and incubation was performed in a thermocycler. These protocols were adapted from the LiAC method (Le Dall, Nicaud and Gaillardin 1994; Chen, Beckerich and Gaillardin 1997) . Protocol 1A is based on the use of a commercial buffer from the Yeastern kit (YLEX Expression Kit, Yeastern Biotech Co., Ltd.). Cells were streaked on a YPD plate and grown for 24 h at 28
• C. Cells were scraped from the agar surface, washed in TE buffer and centrifuged at 3000 rpm at room temperature for 5 min. For 100 single transformations, approximately 5 × 10 9 cells were resuspended in 10 ml of complete YLOS buffer (Yeastern Biotech), which was composed of 9.5 ml of YLOS buffer, 500 μl of 2 M DTT and 500 μl of single-strand carrier DNA (5 mg ml −1 of salmon DNA; Dualsystems AG Biotech). For each transformation, 3 μL of the linearized DNA vector for transformation (∼ 50 ng) was added to 100 μl of the cell/YLOS suspension in a 96-well PCR plate and incubated at 39
• C for 60 min. The cells were directly plated on appropriate selective solid minimal YNB medium. Protocol 1B is similar to protocol 1A without the addition of DTT, replaced by 500μl of water.
Protocol 2 is based on the standard LiAC method. Cells were streaked on YPD plates and grown for 24 h at 28
• C. For 100 single transformations, 15 loopfuls of cells were scraped from the agar surface, washed in 15 ml TE buffer and centrifuged at 3000 rpm at room temperature for 5 min. Cells were resuspended in 10 ml of 0.1 M LiAC, pH 6, and incubated 1 h at 28
• C in order to obtain competent cells. Cells were centrifuged at 2000 rpm at room temperature for 2 min and resuspended in 1 ml of 0.1 M LiAC pH 6. Then 10 μL of cells was transferred into each well of a 96-well PCR plates, gently mixed with 3 μl of linearized DNA vector (∼ 50 ng) and 1 μL of carrier DNA (5 mg ml −1 , Dualsystems AG Biotech), and incubated for 15 min at 28 • C. Following this, 66 μL of reaction buffer (40% PEG, 0.1 M LiAC pH 6) was added to each transformation and mixed gently. The mix was incubated 1 h at 28
• C followed by a 10-min heat shock at 39
• C. The cells were plated on appropriate selective solid minimal YNB medium.
Protease activity test
Protease activity was measured by FRET, using fluorescein thiocarbamoyl-casein (FTC-casein; Thermo Scientific) as a substrate. Hydrolysis of FTC-casein by proteases releases fluorescein molecules, which increases fluorescence. FTC-casein was resuspended in 50 mM phosphate buffer, pH 6.8, at 5 μg ml −1 . We then used 10 μl of 48-h YPD microplate precultures to inoculate 200 μl YNB microplate cultures. After 4 h of growth at 28
• C with agitation, 10 μl of each culture was sampled and mixed with 40 μl of 50 mM phosphate buffer in microtiter plates, at which point 50 μl FTC-casein solution was rapidly added to each cell suspension. Fluorescence emission and cell density were measured every 1 min for 1 h using a microtiter plate reader (Biotek), with an excitation wavelength of 494 nm and an emission wavelength of 517 nm. Vmax was calculated from 10 min to 1 h with a sliding window of 30 min and was calculated in relative fluorescence per min (RFU/min).
Fluorescence microscopy
Microscopy images were taken using a Zeiss Imager.M2 microscope equipped with an HXP 120 C lamp, fluorescence filter 46 to visualize the eYFP fluorescent protein and fluorescence filter 45 to visualize the RedStar2 fluorescent protein (Carl Zeiss).
RESULTS AND DISCUSSION
Yarrowia lipolytica overexpression Gateway vector contruction
In order to take advantage of the widely used Gateway system, we developed an overexpression destination vector for Y. lipolytica compatible with this cloning technology. The Gateway cloning system allows high-efficiency in vitro cloning based on recombination without the requirement of restriction enzymes (Walhout et al. 2000) . We used the ori and ampicillin resistance gene from the pBR322-derived Gateway pDEST vectors from Invitrogen, coupled with the expression cassette structure from Y. lipolytica expression vector JMP62, in which the Gateway recombination cassette was integrated at the cloning site (see materials and methods). Thus, we obtained a vector that contained the ampicillin-resistant marker, the excisable URA3 marker and the Gateway cloning site between the pTEF promoter and the LIP2 terminator. The expression cassette, which was bookended by Zeta sequences for integration at the Zeta docking platform, was digested by NotI or IceuI (Fig. 1A) . For flexibility, either restriction site can be used in the case that one of the restriction sites is present in the cloned gene. This vector allows the cloning of genes either from PCR products with AttB sequences or from cDNA cloned into a Gateway pDONR vector. Simple recombination at the Gateway cloning site gives rise to overexpression vectors that contain the gene of interest (Fig. 1A) . 
Recipient strain construction with the Zeta docking platform
We developed a strain that contained a Zeta platform for locusspecific integration via single-crossing over with the Zeta sequences present in the expression cassettes (Bordes et al. 2007) ; this was to avoid artifactual phenotypes due to random integration in the genome. Most of the Y. lipolytica mutant strains are derived from an original Ura-auxotroph mutant that contains the ura3-302 allele (Barth and Gaillardin 1996) . This mutant contains a SUC2 expression cassette which allows the expression of S. cerevisiae invertase. To delete this expression cassette, we had previously constructed a Zeta docking platform at the ura3-302 allele by inserting the ura3-1462 allele, yielding JMY2033 (Lazar et al. 2013) . This deletion completely removes the URA3 ORF sequence from the URA3 locus in the genome, thus disabling possible URA3 conversion. Yarrowia lipolytica is frequently grown on non-translucid media, which prevents the direct estimation of cell growth via optical density determination at 600 nm. In order to measure cell density with this method, several steps of cell washing are required, which is not suitable for high-throughput analysis of cell growth measurements. An attempt to overcome this limitation was made by introducing a reporter gene that codes for a measurable activity that is proportional to cell density during culture. We therefore used as a reporter the RedStar2 fluorescent protein, expressed under the pTEF constitutive promoter, in order to follow growth by tracking fluorescence emission. These measurements can be conducted in a 96-well microtiter plate reader during the time course of a culture in non-translucid media, just as the optical density can be measured for cultures in translucid media (Morin et al. 2014) . Therefore, in addition to the Zeta platform, we also introduced the expression cassette pTEF-RedStar2 at the URA3 locus (see materials and methods). The resulting strain, JMY2566, constitutively expresses the RedStar2 protein in addition to offering a Zeta docking platform at the URA3 locus (Fig. 1B) . It was subsequently used for the transformation of all Gateway overexpression cassettes.
Validation of Gateway overexpression system
To validate the overexpression system, we first cloned a set of four genes under the control of the constitutive pTEF promoter. These genes coded for proteins with known and measurable phenotypes: two coded for the fluorescent proteins eYFP and RedStar2; S. cerevisiae SUC2 encoded the invertase protein, which allows growth on sucrose; and Y. lipolytica XPR2 coded for the AEP (see materials and methods for construction). Each overexpression cassette was transformed into the recipient strain JMY2566 and PCR was used to verify its correct integration at the Zeta docking platform. Expression of fluorescent eYFP in strain JMY2812 was verified by fluorescence microscopy ( Fig.  2A) . Integration of the pTEF-attB-RedStar2 cassette generated strain JMY2811, which expressed two copies of RedStar2: the newly introduced pTEF-attB-RedStar2 and the pTEF-RedStar2 already present in recipient strain JMY2566. A 40% increase in RedStar2 expression was observed for JMY2811 compared to the control strain JMY2810 (which was constructed by transforming JMY2566 with an empty vector). This increase demonstrated that the new pTEF-attB-RedStar2 construct was able to express RedStar2 efficiently, even though the attB site was present between the promoter and the gene. In addition, the measurable increase caused by the introduction of a second copy of RedStar2 indicates that the pTEF promoter in this expression system is strong enough to enable detection of the overexpression phenotype, even when it involves native genes that are already highly expressed.
To confirm the overexpression phenotypes, we first used the Y. lipolytica XPR2 gene, which codes for AEP, to complement a strain that lacks this protease. All the strains derived from Po1d, which is deleted for XPR2 (Barth and Gaillardin 1996) . Here, the overexpression of XPR2 (strain JMY2813) restored AEP production, as visualized by the halo of hydrolysis on skim-milk plates similar in size to that seen with wild-type strain W29 (Fig. 2B) . Second, the overexpression of the S. cerevisiae invertase gene SUC2 in JMY2566 (which created strain JMY2515) was tested for its ability to restore growth on sucrose. Indeed, strain JMY2515 had a growth profile on sucrose that was similar to growth on glucose, while JMY2566 transformed with the empty vector (control strain JMY2810) did not grow (Fig. 2C) .
These results are a clear demonstration of the efficiency of the Y. lipolytica Gateway system in the expression of homologous, heterologous, intracellular and secreted proteins.
Fluorescent protein for monitoring growth in non-translucid media
The use of a strain that constitutively expressed a fluorescent protein allowed for kinetic growth measurements on nontranslucid media, such as fatty-acid emulsions, skim milk-based media, molasses or any substrate that interferes with the light path in classical optical density measurements. Our strains constitutively expressed the RedStar2 fluorescent protein and enabled kinetic growth measurements in real time in such media though the use of a fluorescence microtiter plate reader. We first used the control strain JMY2810 to determine that the intensity of fluorescence was proportional to optical density in a translucid medium. We found that kinetic OD 600 and kinetic fluorescence measurements were very similar, with the increase in fluorescence being slightly delayed compared to OD 600 readings (Fig. 3A) .
Second, we measured the growth (via fluorescence) over time in a skim milk-based (non-translucid) medium of an Aep + strain (JMY2813) that overexpressed XPR2 and two Aep − strains (JMY2810 and JMY2815) in which this protease was deleted (Fig. 3B) . The Aep + strain (JMY2813) showed increased growth in this medium compared to the Aep − strains, as expected, due to its ability to degrade skim milk proteins. Clarification of the medium was visually detectable for JMY2813, while the medium of the Aep − strains remained non-translucid.
These three strains had similar growth (OD 600 ) and fluorescence profiles on translucid glucose-based medium (data not shown).
High-throughput transformation methods
The Gateway cloning strategy enables the creation of a large set of vectors and consequently requires an efficient method for high-throughput transformation. Towards this end, we developed miniaturized protocols to adapt single-tube trans- formation methodologies to the 96-well plate format. This format can be used by most liquid-handling robots and is compatible with the requirements for commercially available highthroughput 96-well plasmid preparation kits. The final reaction volume was set at 200 μL, thus allowing transformation in 96-well plates and the use of a thermocycler for the various incubation steps. Three methods were tested: a one-step protocol derived from Chen, Beckerich and Gaillardin ( 1997) that used the YLOS kit from Yeastern R (Protocol 1A); a second protocol similar to the first, but without DTT, in order to favor locus, rather than random, integration (protocol 1B); and the standard method adapted from Le Dall, Nicaud and Gaillardin (1994) , with volumes modified to fit in 96-well plates, i.e. 200 μl (protocol 2). The protocols are described in the materials and methods section. Three strains were used: JMY2566 and JMY2033, which both have a Zeta docking platform; and JMY2101, which lacks such a platform (Table 1) . For each transformation protocol, two different Gateway vectors were tested: JMP1598, which overexpressed SUC2; and JMP1600, which overexpressed RedStar2.
Combining all strains and vector transformations, the transformation rates for protocols 1 and 2 were, respectively, 2.2 × 10 3 transformants per μg of DNA and 1.3 × 10 3 transformants per μg of DNA; clearly, transformation was more successful with the one-step protocol 1A (Fig. 4) . In our hands, the one-step protocol without DTT generated very few transformants and was not explored further. However, the transformation rate was strain-dependant: it was 2-fold higher with JMY2033 compared to JMY2566 (Fig. 4 ) and 4-fold higher compared to JMY2101 (data not shown). These differences were observed with both protocols. Overall, both protocols adapted for 96-well plates yielded good transformation rates and were easy to implement. Strains JMY2033 and JMY2566 contained a Zeta docking platform, which enabled locus-specific integration. The proportion of locus integration versus random integration was verified by PCR, as described in the materials and methods section. Using this method, we were not able to rule out a double integration event; however, we never detected a transformant that showed evidence of both locus integration and random integration. Among the 708 transformants obtained from JMY2033, JMY2566 and the two plasmids, 389 were analyzed for locus integration. With protocol 1A, only 17.3% of the transformants presented integration at the Zeta locus, while the success rate reached 82.5% with protocol 2 (Fig. 4) .
Thus, depending on the type of integration required (random or Zeta platform; see next section), either protocol 1A or protocol 2 could be used.
Variation in enzyme activity in random-integration transformants
In order to evaluate the variation in enzyme activity among clones that demonstrated random integration, strain JMY2566 (Aep − ) was transformed with vector JMP1603 (XPR2 overexpression) using protocol 1A. Extracellular protease activity was measured in 96 transformants using the FTC-casein substrate as described in materials and methods. The distribution of protease activity is depicted in Fig. 5 . Among the transformants, three displayed no detectable activity (Vmax ≤ 0), 88% showed a Vmax within one standard deviation of the mean, and two clones had a Vmax more than two standard deviations from the mean, with one of these showing a 61% increase compared to the mean. Thus with protocol 1A, we were able to obtain mutants that varied in their phenotypes, some of which displayed remarkably high levels of protease activity. 
CONCLUDING REMARKS
Vectors and strains for Gateway high-throughput overexpression strategies were developed. In addition, the recipient strain contained a fluorescent reporter gene to enable growth monitoring in non-translucid media. Miniaturized protocols for the high-throughput transformation of Y. lipolytica were established.
